CEP-40125

• Description :

  CEP-40125 (RXDX-107) is a modified form of Bendamustine (HY-13567), a DNA cross-linking agent that may cause DNA damage and cell apoptosis. CEP-40125 (RXDX-107) is formed by encapsulating the alkyl ester form of Bendamustine in human serum albumin[1][2].

• CAS Number :

  [1456608-94-8]

• Product Name Alternative :

  RXDX-107

• UNSPSC :

  12352005

• Target :

  Apoptosis

• Type :

  Reference compound

• Related Pathways :

  Apoptosis

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/cep-40125.html

• Smiles :

  O=C(CCCC1=NC2=CC(N(CCCl)CCCl)=CC=C2N1C)OCCCCCCCCCCCC

• Molecular Formula :

  C28H45Cl2N3O2

• Molecular Weight :

  526.58

• References & Citations :

  [1]Pharmaceutical prodrugs and methods of their preparation and use. WO2018013783.|[2]Croasdell G. The 34th Annual JP Morgan Healthcare Conference. San Francisco, California, USA-January 11-14, 2016[J]. Drugs of the Future, 2016, 41 (1) .

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 1